MI-VAD, Inc. is pleased to announce the appointment of Feras Bader MD, of Abu Dhabi, UAE to our Technical Advisory Board.

“Over the past 15 years since I specialized in the field of advanced heart failure and transplantation, I have seen many patients die prematurely as their condition progressed despite available medication and device therapies. Although heart transplantation remains the definitive solution in end-stage heart failure, it is severely limited by the shortage of organ donors, leaving the future very promising for advances in artificial heart pumps. While technology continues to flourish in this field, there are still important limitations. With MI-VAD, I am very optimistic that we can finally have a “smart pump”; one that supports the heart but does not burden the body with various complications”.

Dr. Bader is a Staff Physician in the Heart & Vascular Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Bader served as Medical Director of the Heart Failure Program and Director of the Advanced Heart Failure and Transplant Fellowship Program at the University of Utah Hospital in Salt Lake City, Utah. He was also Associate Professor of Medicine and Cardiology at the University of Utah, specializing in the field of Advanced Heart Failure and Transplantation. Dr. Bader also helped establish an advanced heart failure program for the Kuwait Ministry of Health, adding valuable regional experience to his experience practicing in the US.

He earned his medical degree from the University of Jordan School of Medicine in Amman, Jordan. He completed his residency in Internal Medicine as well as a fellowship in Advanced Heart Failure and Transplant at the Yale University School of Medicine in Connecticut, US. He then completed a fellowship in Cardiovascular Medicine at the University of Utah School of Medicine, where he also obtained a Master’s Degree in Clinical Investigation.

Dr. Bader is American Board certified in Internal Medicine, Cardiovascular Diseases, Echocardiography, and Advanced Heart Failure and Transplant Cardiology. His research interests include various aspects of ventricular assist devices, hemodynamics and cardiorenal interaction in heart failure, as well as noninvasive diagnosis of rejection in heart transplantation. He has participated in many single and multicenter trials and has published several articles in peer reviewed journals. He is a Fellow of the American College of Cardiology.

MI-VAD, Inc. is a privately owned developmental stage medical device company that is continuing its development of a novel and potentially revolutionary minimally invasive mechanical blood circulatory pump, or ventricular assist device (VAD) that can change the management of end-stage heart failure.  For more information, contact us at info@mivadinc.com